The Interventional Orthobiologics Blog

Research Updates on the Bedside Dosing of Bone Marrow Concentrate

Now that dosing PRP has become a good thing, the next domino to fall for dosing is bone marrow concentrate. Up until this past month, outside of our 2014 paper, there wasn’t much out there about a simple bedside method to get to the right dose. Now, with several new papers being published, has that…read more

Regenexx Morning Orthobiologics Update

This past week, I’ve been involved in creating a new daily content feature on Linkedin called the “Morning Orthobiologics Update”. Let’s dig in. Our Scrolling World Like many people, I get bombarded with new information. Have you ever noticed that you clicked on something, and then your social media feeds began to show you that…read more

Knee Ligament Laxity vs. Torn Ligaments: Interventional Orthobiologics vs. Surgery

There’s an interesting duality between the understanding that loose ligaments should be treated with orthobiologics and the old-school orthopedic surgery approach that only completely torn ligaments are important and can be operated on. This was recently thrust into my consciousness by a sports medicine physician with whom I shared a patient who doggedly claimed that…read more

My 2024 PRP RCT Infographic 2.0

I blog about what comes my way as a practicing physician using orthobiologics and the medical director of Regenexx. In many ways, LinkedIn becomes my professional sounding board with other physician colleagues. This past week, I posted my 2024 PRP RCT infographic, which was very well received. However, one colleague pointed out that I should…read more

QC Kinetix Goes from Mastering the Upsell to Reducing Costs?

I have often written about QC Kinetix because they’re hard to miss. They have bombarded the airwaves across the US, causing countless physician colleagues to reach out and ask, “What the heck is this?” Now I hear that the company has decided to create a program to save corporations money on their elective orthopedic surgery…read more

My 2024 PRP RCT Infographic

[A companion analysis to this blog was posted after this piece was published and can be seen here.] Every year, I perform a deep dive into the orthobiologic literature to see what’s been published. This is part of my job as CMO of Regenexx, and it’s also a great opportunity to produce an infographic that…read more